Ignite Creation Date:
2025-12-24 @ 9:07 PM
Ignite Modification Date:
2026-01-02 @ 7:00 AM
Study NCT ID:
NCT05103904
Status:
RECRUITING
Last Update Posted:
2024-12-27
First Post:
2021-10-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
Sponsor:
Emory University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-19
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-11-04
Completion Date Type:
ESTIMATED
First Submit Date:
2021-10-11
First Submit QC Date:
None
Study First Post Date:
2021-11-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-23
Last Update Post Date:
2024-12-27
Last Update Post Date Type:
ACTUAL